Document:

Exhibit

Exhibit 10.2

AMENDMENT NO. 5 TO  
THE PROFIT SHARING PLAN OF 
QUEST DIAGNOSTICS INCORPORATED
The Profit Sharing Plan of Quest Diagnostics Incorporated, as presently maintained under an amendment and restatement effective as of January 1, 2016 (the “Plan”), is hereby amended in the following respects, effective as of the dates set forth below:
1.    Paragraph (a) of Section 3.2 of the Plan (“Matching Contributions”) is amended in its entirety to read as follows effective January 1, 2020:
(a)    With respect to Deferral Compensation paid in paychecks up to and including Participants’ May 29, 2020 paycheck, the Employer shall make Employer Matching Contributions to the Trust Fund equal to 100% of the Employee Pre-Tax Contributions made by each Eligible Employee with respect to each payroll period, but taking into account only those Employee Pre-Tax Contributions made by him with respect to such payroll period which are made at a rate that does not exceed 5% of his Deferral Compensation (but only up to the Code Section 401(a)(17)(B) limit).  Employer Matching Contributions may be made, at the discretion of Quest Diagnostics, solely in cash, solely in Quest Diagnostics Common Stock or in a combination of cash and Quest Diagnostics Common Stock.  Employer Matching Contributions will not be made with respect to Deferral Compensation paid in Participants’ paychecks issued after May 29, 2020, except as otherwise provided in Section 3.2(e). 
2.    A new paragraph (e) is added to Section 3.2 to read in its entirety as follows:
(e)    Anything in this Section 3.2 to the contrary notwithstanding, with respect to any paychecks issued for a payroll period occurring after May 29, 2020 specified by its Senior Vice President and Chief Human Resources Officer (“CHRO”), the Employer by action of the CHRO may elect to make discretionary Employer Matching Contributions in an amount equal to a uniform percentage (not to exceed 100%) of the Employee Pre-Tax Contributions made by each Eligible Employee with respect to such payroll period which 

1

are made at a rate that does not exceed 5% of his Deferral Compensation (but only up to the Code Section 401(a)(17)(B) limit).
3.    Section 3.6 of the Plan (“Actual Deferral Percentage Test Safe Harbor”) is amended in its entirety to read as follows effective as of January 1, 2020:
		
	3.6
	Code Section 401(k) Actual Deferral Percentage Test

(a)    For each Plan Year, the Regular Pre-Tax Contributions made on behalf of Highly Compensated Employees shall satisfy the actual deferral percentage test set forth in Code Section 401(k)(3) and Regulation §1.401(k)-2, which are incorporated herein by reference (the “ADP Test”), using the current year testing method.  For any Plan Year commencing with 2021, the CHRO may, on behalf of the Employer, elect to apply the ADP Test on a prior year basis, provided that a change to the prior year method is permitted by Regulation §1.401(k)-2(c)(1).  Any such election shall be considered an amendment to the Plan permitted by Section 9.1 and shall be evidenced by a written instrument executed not later than the last day of the Plan Year for which such amendment is to be effective. 
(b)    In order to prevent the limitation of the ADP Test from being exceeded in any Plan Year, the Employer may, in its sole discretion, either limit the Regular Pre-Tax Contributions made on behalf of Highly Compensated Employees, utilize any of the correction methods permitted by Regulation §1.401(k)-2(b)(1), or any combination thereof.
4.    Section 3.9 of the Plan (“Average Contribution Percentage Test Safe Harbor”) is amended in its entirety to read as follows effective as of January 1, 2020:  
		
	3.9
	Code Section 401(m) Average Contribution Percentage Test

(a)    For each Plan Year, the Employer Matching Contributions made on behalf of Highly Compensated Employees shall satisfy the average contribution percentage test set forth in Code Section 401(m)(2) and Regulation §1.401(m)-2, which are incorporated herein by reference (the “ACP Test”), using the current year testing method.  For any Plan Year commencing with 2021, the CHRO may, on behalf of the Employer, elect to apply the ACP Test on a prior year basis, provided that a change to the prior year method is permitted by Regulation §1.401(m)-2(c)(1).  Any such election shall be considered an amendment to 

2

the Plan permitted by Section 9.1 and shall be evidenced by a written instrument executed not later than the last day of the Plan Year for which such amendment is to be effective.
(b)    In order to prevent the limitation of the ACP Test from being exceeded in any Plan Year, the Employer may, in its sole discretion, either limit the Employer Matching Contributions made on behalf of Highly Compensated Employees, utilize either of the correction methods permitted by Regulation §1.401(m)-2(b)(1), or any combination thereof.
5.    Paragraph (b) of Section 6.1 (“Loans to Participants”) is amended as follows effective as of March 27, 2020: 
(b)    Except with respect to pre-existing loans transferred to or merged into this Plan under subsection (k), or as set forth in the last sentence of this subsection (b), a Participant may have only one (1) loan outstanding at any time.  For purposes of this subsection (b), a loan that is in default under subsection (e) is treated as outstanding.  There must be a minimum of fourteen (14) days (or such other period determined by the Plan Administrator) between the payoff of one Plan loan and the issuance of a new loan, provided that the minimum-day restriction may be waived under procedures established by the Plan Administrator.  Notwithstanding the foregoing, a Participant who is a qualified individual as defined in Section 2202(b) of the Coronavirus Aid, Relief, and Economic Security Act may receive a loan subject to the increased limit on loans set forth therein, even if the Participant already has a loan outstanding.   
As evidence of its adoption of this Amendment, Quest Diagnostics Incorporated has caused this Amendment to be executed by its Senior Vice President and Chief Human Resources Officer on      
April 14, 2020.
QUEST DIAGNOSTICS INCORPORATED
By:   /s/ Cecilia K. McKenney     
Name:    Cecilia McKenney    
Title:     SVP and Chief Human Resources Officer       

3Exhibit 10.1

 

 

 Exhibit 10.1
 U.S. Small Business Administration
 NOTE
 

 SBA Loan #
 1259977203
 SBA Loan Name
 TRANSLUX CORPORATION
 Date
 4/20/2020
 Loan Amount
 810,800.00
 Interest Rate
 1.00%
 Borrower
 TRANSLUX CORPORATION
 Operating Company
 Lender
 Enterprise Bank & Trust
 

 1.
 PROMISE TO PAY
 In return for the Loan, Borrower promises to pay to the order of Lender the amount of eight hundred ten thousand and eight hundred Dollars, interest on the unpaid principal balance, and all other amounts required by this Note.
 2.
 DEFINITIONS:
 “Collateral” means any property taken as security for payment of this Note or any guarantee of this Note.
 “Guarantor” means each person or entity that signs a guarantee of payment of this Note.
 “Loan” means the loan evidenced by this Note.
 “Loan Documents” means the documents related to this loan signed by Borrower, any Guarantor, or anyone who pledges collateral.
 “SBA” means the Small Business Administration, an Agency of the United States of America.
 

 1
  
  

  
 
 

 

 

 3.
 PAYMENT TERMS:
 Borrower must make all payments at the place Lender designates.  The payment terms for this Note are:
 The Repayment Terms herein are subject to Sections 1102 and 1106 of the Coronavirus Aid, Relief, and Economic Security Act (CARES ACT).
 Maturity: This Note will mature in 2 years from the date of the Note.
 The interest rate shall be 1.00%.
 The interest rate identified in the Note may not be changed during the life of the Loan unless changed in accordance with SOP 50 10.
 Payment: 6 Months of Principal and Interest will be deferred.
 Unless otherwise determined, Borrower must pay principal and interest payments of $45,616.11 monthly beginning 7 months from the date of Note; payments must be made on the tenth calendar day in the months they are due.
 Lender will apply each installment payment first to pay interest accrued to the day Lender receives the payment, then to bring principal current, then to pay any late fees, and will apply any remaining balance to reduce principal.
 Lender must adjust the payment amount at least annually as needed to amortize principal over the remaining term of the Note.
 All remaining principal and accrued interest is due and payable 2 years from date of Note.
 Late Charge: If a payment on this Note is more than 10 days late, Lender may charge Borrower a late fee of up to 5 % of the unpaid portion of the regularly scheduled payment.
 4.
 DEFAULT:
 Borrower is in default under this Note if Borrower does not make a payment when due under this Note, or if Borrower or Operating Company:
 A.
 Fails to do anything required by this Note and other Loan Documents;
 B.
 Defaults on any other loan with Lender;
 C.
 Does not preserve, or account to Lender’s satisfaction for, any of the Collateral or its proceeds;
 2
  

  
  
 D.
 Does not disclose, or anyone acting on their behalf does not disclose, any material fact to Lender or SBA;
 E.
 Makes, or anyone acting on their behalf makes, a materially false or misleading representation to Lender or SBA;
 F.
 Defaults on any loan or agreement with another creditor, if Lender believes the default may materially affect Borrower’s ability to pay this Note;
 G.
 Fails to pay any taxes when due;
 H.
 Becomes the subject of a proceeding under any bankruptcy or insolvency law;
 I.
 Has a receiver or liquidator appointed for any part of their business or property;
 J.
 Makes an assignment for the benefit of creditors;
 K.
 Has any adverse change in financial condition or business operation that Lender believes may materially affect Borrower’s ability to pay this Note;
 L.
 Reorganizes, merges, consolidates, or otherwise changes ownership or business structure without Lender’s prior written consent; or
 M.
 Becomes the subject of a civil or criminal action that Lender believes may materially affect Borrower’s ability to pay this Note.
 5.
 LENDER’S RIGHTS IF THERE IS A DEFAULT:
       Without notice or demand and without giving up any of its rights, Lender may:
 A.
 Require immediate payment of all amounts owing under this Note;
 B.
 Collect all amounts owing from any Borrower or Guarantor;
 C.
 File suit and obtain judgment;
 D.
 Take possession of any Collateral; or
 E.
 Sell, lease, or otherwise dispose of, any Collateral at public or private sale, with or without advertisement.
 6.
 LENDER’S GENERAL POWERS:
 Without notice and without Borrower’s consent, Lender may:
 A.
 Bid on or buy the Collateral at its sale or the sale of another lienholder, at any price it chooses;
 3
  

  
  
  
 B.
 Incur expenses to collect amounts due under this Note, enforce the terms of this Note or any other Loan Document, and preserve or dispose of the Collateral.  Among other things, the expenses may include payments for property taxes, prior liens, insurance, appraisals, environmental remediation costs, and reasonable attorney’s fees and costs.  If Lender incurs such expenses, it may demand immediate repayment from Borrower to add the expenses to the principal balance;
 C.
 Release anyone obligated to pay this Note;
 D.
 Compromise, release, renew, extend or substitute any of the Collateral; and
 E.
 Take any action necessary to protect the Collateral or collect amounts owing on this Note.
 7.
 WHEN FEDERAL LAW APPLIES:
 When SBA is the holder, this Note will be interpreted and enforced under federal law, including SBA regulations.  Lender or SBA may use state or local procedures for filing papers, recording documents, giving notice, foreclosing liens, and other purposes.  By using such procedures, SBA does not waive any federal immunity from state or local control, penalty, tax, or liability.  As to this Note, Borrower may not claim or assert against SBA any local or state law to deny any obligation, defeat any claim of SBA, or preempt federal law.
 8.
 SUCCESSORS AND ASSIGNS:
 Under this Note, Borrower and Operating Company include the successors of each, and Lender includes its successors and assigns.
 9.
 GENERAL PROVISIONS:
 A.
 All individuals and entities signing this Note are jointly and severally liable.
 B.
 Borrower waives all suretyship defenses.
 C.
 Borrower must sign all documents necessary at any time to comply with the Loan Documents and to enable Lender to acquire, perfect, or maintain Lender’s liens on Collateral.
 D.
 Lender may exercise any of its rights separately or together, as many times and in any order it chooses.  Lender may delay or forgo enforcing any of its rights without giving up any of them.
 E.
 Borrower may not use an oral statement of Lender or SBA to contradict or alter the written terms of this Note.
 F.
 If any part of this Note is unenforceable, all other parts remain in effect.
 4
  

  
  
  
 G.
 To the extent allowed by law, Borrower waives all demands and notices in connection with this Note, including presentment, demand, protest, and notice of dishonor.  Borrower also waives any defenses based upon any claim that Lender did not obtain any guarantee; did not obtain, perfect, or maintain a lien upon Collateral; impaired Collateral; or did not obtain the fair market value of Collateral at a sale.
 10.
  
STATE-SPECIFIC PROVISIONS:
 ORAL AGREEMENTS.  ORAL OR UNEXECUTED AGREEMENTS OR COMMITMENTS TO LOAN MONEY, EXTEND CREDIT OR TO FOREBEAR FROM ENFORCING REPAYMENT OF A DEBT INCLUDING PROMISES TO EXTEND OR RENEW SUCH DEBT ARE NOT ENFORCEABLE, REGARDLESS OF THE LEGAL THEORY UPON WHICH IT IS BASED THAT IS IN ANY WAY RELATED TO THE CREDIT AGREEMENT.  TO PROTECT YOU (BORROWER(S)) AND US (CREDITOR) FROM MISUNDERSTANDING OR DISAPPPOINTMENT, ANY AGREEMENTS WE REACH COVERING SUCH MATTERS ARE CONTAINED IN THIS WRITING, WHICH IS THE COMPLETE AND EXCLUSIVE STATEMENT OF THE AGREEMENT BETWEEN US, EXCEPT AS WE MAY LATER AGREE IN WRITING TO MODIFY IT.
 11.
 BORROWER’S NAME(S) AND SIGNATURE(S):
 By signing below, each individual or entity becomes obligated under this Note as Borrower.
 

 TRANSLUX CORPORATION
 

 By: /s/ Todd Dupee                                           
 Todd Dupee, Senior Vice President of TransLux Corporation
 

 By: /s/ Thomas E. Durkin, III                             
 Thomas E. Durkin, III, Executive Vice President/Secretary of TransLux Corporation
 

 

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]